The vitamin A metabolite retinoic acid (RA) has potent immunomodulatory properties that affect T cell differentiation, migration and function. However, the precise role of RA metabolism in T cells remains unclear. Catabolism of RA is mediated by the Cyp26 family of cytochrome P450 oxidases. We examined the role of Cyp26b1, the T cell-specific family member, in CD4 + T cells. Mice with a conditional knockout of Cyp26b1 in T cells (Cyp26b1 2/2 mice) displayed normal lymphoid development but showed an increased sensitivity to serum retinoids, which led to increased differentiation under both inducible regulatory T (iT reg ) cell-and T H 17 cell-polarizing conditions in vitro. Further, Cyp26b1 expression was differentially regulated in iT reg and T H 17 cells. Transfer of naïve Cyp26b1 2/2 CD4 + T cells into Rag1 2/2 mice resulted in significantly reduced disease in a model of T cell-dependent colitis. Our results show that T cell-specific expression of Cyp26b1 is required for the development of T cell-mediated colitis and may be applicable to the development of therapeutics that target Cyp26b1 for the treatment of inflammatory bowel disease.
Introduction
Retinoic acid (RA) is a vitamin A metabolite that plays a critical role during embryonic development [1] and has important immunomodulatory functions in adults [2] . For example, vitamin A deficiency can lead to profound immunological impairments in children such as an increased susceptibility to infections [3] . RA binds nuclear RA receptors (RARs) and retinoid X receptors which transcriptionally regulate genes that contain specific RA response elements [4] . Synthesis of RA from vitamin A is a tightly controlled process that enables specialized cells such as dendritic cells (DCs) to modulate the activation, gut homing ability and function of CD4 + T cells [5] . Additionally, RA has been shown to strongly promote the differentiation of inducible regulatory T cells (iT reg cells) in the presence of TGF-b [6] and can modulate the migration and function of T helper 17 (T H 17) cells in the intestine [7] . Interestingly, it has recently been shown that RA signaling occurs in T cells during the early stages of inflammation [8] , suggesting that RA may be required for optimal effector T cell responses. Indeed, optimal T H 1 effector T cell responses during Toxoplasma gondii infection require RA signaling [9] . Thus, RA signaling is critical for both effector and regulatory T cell function.
Despite the importance of RA signaling in T cells, very little is known about the molecular mechanisms that control RA bioavailability, signaling and metabolism in T cells and how these processes ultimately affect T cell differentiation and function. The cytochrome P450 family 26, subfamily b, polypeptide 1 (Cyp26b1) enzyme has been recently identified as the primary negative regulator of RA responsiveness in T cells [10] . Cyp26b1 is highly induced in the presence of RA and is downregulated by the cytokine TGF-b1 [10] . Cyp26b1 was also shown to modulate the RA-dependent expression of the gut-homing receptor CCR9 on T cells [10] . Thus, regulation of RA signaling by Cyp26b1 likely plays a central role in T cell function. However, the specific role of Cyp26b1 in T cells has not been investigated in vivo.
RA has been shown to play an important role in mucosal immune responses and oral tolerance. Intestinal cell populations including DCs and epithelial cells are significant sources of RA [2] and vitamin A deficiency has a dramatic effect on intestinal immunity and physiology [11] . Further, administration of RA can protect mice from chemically-induced colitis and the ratio of Foxp3 to IL-17 expression increased in colon biopsies treated with RA from ulcerative colitis patients [12] . The aim of the present study was to assess the role of Cyp26b1 in regulating RAdependent T cell immune responses in the intestine. We show that although T cell-intrinsic expression of Cyp26b1 is dispensable for T cell development, Cyp26b1-deficient T cells display enhanced iT reg and T H 17 cell differentiation in vitro. Further, following adoptive transfer into immunodeficient hosts, Cyp26b1-deficient T cells induced significantly less intestinal inflammation. Together, our results identify a critical role for Cyp26b1-dependent catabolism of RA in T cell differentiation and function.
Results

Expression of Cyp26b1 is Dispensable for T Cell Development
Mice with a germline deletion of Cyp26b1 display severe bone and limb abnormalities and die in utero [14] . In order to assess the role of Cyp26b1 in adult T cells, we generated mice with a T cellspecific deletion of Cyp26b1 by breeding Cyp26b1 fl/fl mice with mice expressing the Cre recombinase under the control of the Cd4 promoter/enhancer (here termed Cyp26b1 2/2 mice). Cyp26b1 
Mice
The role of RA signaling in the development of thymic-derived naturally-occurring T reg (nT reg ) cell development has not been examined in detail, although RAR-activating retinoids have been shown to be produced within the thymus [15] . We examined the frequency and function of nT reg cells in Cyp26b1 2/2 mice. We observed equivalent frequencies of nT reg cells in the spleens of Cyp26b1 fl/fl and Cyp26b1 2/2 mice (Figure 2A ), suggesting that RA signaling is not a major determinant of nT reg cell development. Further, Cyp26b1 was dispensable for the suppressive ability of nT reg cells ( Figure 2B ), as nT reg cells from either Cyp26b1 fl/fl or Cyp26b1 2/2 mice were able to suppress effector T cell proliferation equivalently. Thus, Cyp26b1-dependent RA metabolism is not required for nT reg cell development and suppressive function.
Cyp26b1 Modulates iTreg and TH17 Cell Polarization In Vitro
RA plays an important role in the differentiation of naive CD4 + T cells into iT reg and T H 17 cells [6, 7, 16] Figure 3A ). Following stimulation under T H 17 cell-promoting conditions, we observed a marked increased frequency of IL-17a-producing CD4
+ T cells in the absence of Cyp26b1 ( Figure 3B ). These results are consistent with the expression pattern of Cyp26b1 and suggest that induction of Cyp26b1 is required for limiting T H 17 cell differentiation. Surprisingly, we also found that the absence of Cyp26b1 resulted in heightened frequencies of
+ iT reg cells ( Figure 3C ), despite the low levels of Cyp26b1 expression observed in iT reg cells. These results suggest that metabolism of RA is important for limiting iT reg and T H 17 cell responses. However, we had not added any exogenous RA to these cultures, suggesting that low levels of serum retinoids affect iT reg and T H 17 cell differentiation in the absence of Cyp26b1. To directly test this, we repeated the experiment in serum-free media. Under these conditions, we found equivalent frequencies of iT reg cells and T H 17 cells following stimulation of CD4 + T cells from both Cyp26b1 fl/fl and Cyp26b1 2/2 mice. Thus, Cyp26b1 regulates RA signaling in T cells and is critical for limiting iT reg and T H 17 cell differentiation. Further, these results suggest that physiological levels of RA in naïve cells impacts effector T cell differentiation.
Cyp26b1-deficient T Cells Fail to Induce Intestinal Inflammation
Based on our in vitro results demonstrating a role for Cyp26b1 in limiting iT reg and T H 17 cell differentiation, we next examined the role of Cyp26b1 in T cell differentiation in vivo. We employed a well-characterized model of T cell-dependent intestinal inflammation [17] . Transfer of CD4 mice resulted in significant weight loss and morbidity associated with intestinal inflammation (Figure 4A,B) . In contrast, transfer of T cells isolated from Cyp26b1 2/2 mice resulted in significantly attenuated disease progression, including decreased weight loss and less severe intestinal inflammation. In contrast to our in vitro results, polyclonal stimulation of cells isolated from mesLNs or spleens resulted in no striking differences in the production of IL17a by Cyp26b1 fl/fl and Cyp26b1 2/2 T cells ( Figure 4C ). In addition, the frequency of Foxp3 + T reg cells in the mesLN and spleen of Rag1 2/2 mice that received either Cyp26b1 fl/fl or Cyp26b1 2/2 T cells were also similar ( Figure 4D ). Despite equivalent numbers of Cyp26b1 fl/fl and Cyp26b1 2/2 CD4 + T cells in the intestine as measured by Cd4 gene expression ( Figure 4E ), we observed reduced levels of Il17a gene expression in Rag1 2/2 mice that received Cyp26b1 2/2 T cells ( Figure 4F ). Further, consistent with reduced disease, we observed decreased expression of the pro-inflammatory cytokines Ifng and Tnfa in the intestine of Rag1 2/2 mice that received Cyp26b1 2/2 T cells ( Figure 4G ). The reduced capacity of Cyp26b1 2/2 T cells to cause disease was not due to an increase in T reg cells in the intestine, based on Foxp3 gene expression ( Figure 4H ). Thus, Cyp26b1 is critical for the development of pathological T cell responses in the intestine.
Cyp26b1-deficient T cells do not have altered intestinal
homing molecule expression. We next assessed whether Cyp26b1 2/2 T cells have an impaired ability to express intestinal homing molecules as a possible reason for why these T cells failed to cause disease in our colitis transfer model. Isolated Cyp26b1 fl/fl and Cyp26b1 2/2 T cells showed no difference in integrin a4b7 surface expression after stimulation with or without AtRA ( Figure 5A ). Isolated Cyp26b1 fl/fl and Cyp26b1 2/2 T cells were also stimulated to express the RA-inducible chemokine receptor CCR9 but showed no differences in surface expression upon stimulation with AtRA ( Figure 5B) . Further, Cyp26b1 fl/fl and Cyp26b1 2/2 T cells polarized to T H 17 and T reg cell lineages showed no differences in gene expression of the homing molecules a4b7 and CCR9 or the transcription factor BATF recently been shown to regulate RA-induced expression of these homing molecules [18] ( Figure 5C ). Thus, Cyp26b1 in T cells does not regulate RA-induced expression of intestinal homing molecules.
Discussion
The Cyp26 family of enzymes are critical for limiting RA responses in vivo. For example, lack of Cyp26 during embryogenesis results in severe developmental defects [19, 20] . RA signaling in T cells has been shown to be regulated by Cyp26b1 [10] . Our study aimed to better characterize how control of RA metabolism and responsiveness by Cyp26b1 affects effector T cell differentiation and function in vivo. To do so, we generated a T cell-specific conditional knockout of Cyp26b1 in mice. It is known that RA signaling is not required for normal hematopoiesis but can regulate precursors of the myeloid compartment [21] . On the other hand, deficiency in RAR signaling in T cells leads to significant activation defects [9] . However, an involvement of Cyp26b1-dependent RA metabolism during T cell development has not been investigated previously. It is known that infants exposed to retinoids in utero has been shown to develop malformations of various organs including the thymus [22] . We did not observe any gross developmental defects in Cyp26b1 2/2 mice, which were completely viable throughout adulthood. In terms of lymphoid development, Cyp26b1 2/2 mice displayed normal levels of CD4 + and CD8 + populations in the thymus, spleen and mesLN. Thus, our results suggest that RA metabolism in T cells has little effect on normal lymphoid development.
RA has paradoxical roles in controlling the balance between iT reg and T H 17 cell differentiation: RA promotes T reg cell differentiation at the expense of T H 17 cell development [16, 23] , yet T H 17 cells require physiological concentrations of RA for development and migration to the intestine [7] . Another study recently found that RA and TGF-b together induce histone modifications at the Foxp3 locus that promote the stability of iT reg cells [24] . Furthermore, the RA-inducible microRNA miR-10a was found to be expressed in both nT reg and iT reg cells, playing an important role in blocking the plasticity of T reg cells [25] . Deficiency in Cyp26b1 led to increased frequencies of both iT reg and T H 17 cells suggesting that Cyp26b1 plays a role in limiting the differentiation of these T cell lineages. This effect was dependent on the presence of retinoids since serum-free culture conditions eliminated these differences, identifying a role for serum retinoids in T cell differentiation in the absence of Cyp26b1 in vitro. Based on our findings, we propose that Cyp26b1 can alter T cell sensitivity to endogenous retinoids during iT reg and T H 17 cell differentiation and plays a role in determining T cell responsiveness to RA.
We also identified a role for T cell-intrinsic expression of Cyp26b1 in vivo. We found that transfer of Cyp26b1 with our observed comparable suppressive function between Cyp26b1 fl/fl and Cyp26b1 2/2 T reg cells in vitro, the role of Cyp26b1 in T reg cell function in our T cell transfer colitis model is likely negligible.
The transcription factor BATF was recently shown to regulate the RA-inducible T H cell expression of intestinal homing receptors [18] . To assess whether Cyp26b1 2/2 T cells have an impaired migratory ability, we characterized the ability of Cyp26b1 2/2 T cells to express RA-inducible intestinal homing molecules integrin a4b7 and the chemokine receptor CCR9 but found no altered capacity of surface expression. Similarly, expression of BATF, Itga4, Itgb7, and Ccr9 were comparable in Cyp26b1 fl/fl and Cyp26b1 2/2 T cells polarized to become T H 17 and T reg cells in vitro. Taken together, our results suggest that the role of RA metabolism in T cell function occurs predominantly in the intestinal tissues, consistent with the high levels of RA synthesizing enzymes expressed in the intestine [26] [27] [28] . Thus, the role of Cyp26b1 in promoting the development of T cell-mediated pathology in the intestine does not involve shifting the T reg /T H 17 balance but potentially involves modulating effector T cell function at the site of inflammation. In closing, we have shown that Cyp26b1 can limit the differentiation of iT reg and T H 17 cells and is differentially expressed by these lineages to fine tune RA responsiveness. Cyp26b1 in T cells was demonstrated to be required for the development of T cell-mediated chronic inflammation in the colon, potentially by regulating T cell effector function in the intestinal tissue. Thus, Cyp26b1 may serve as a novel therapeutic target to treat inflammatory bowel disease.
Materials and Methods
Ethics Statement
Experiments were approved by the University of British Columbia Animal Care Committee (Protocol number A11-0329) and were in accordance with the Canadian Guidelines for Animal Research.
Mice
Cyp26b1
fl/fl mice were generated asdescribed [13] . Cyp26b1 fl/fl mice were crossed with Cd4-Cre mice to generate T cell-specific Cyp26b1 2/2 knockout mice. Rag1 2/2 mice were originally obtained from Jackson Labs. All mice were bred and maintained under specific pathogen-free conditions in house.
T Cell Polarization and Flow Cytometry
Spleens and lymph nodes were passed through 70 mm strainers and pooled before isolation of CD4 + T cells using EasySep mouse CD4
+ enrichment kits on a RoboSep (STEMCELL). 5610 5 cells were cultured onto plates coated with 1 mg/ml a-CD3/a-CD28 under either iT reg cell-(10 ng/ml IL-2 and TGF-b), or T H 17 cell-(1 ng/ml TGF-b, 10 ng/ml IL-1b, IL-6, IL-23, TNF-a, 10 mg/ml a-IL-4 and a-IFN-c) polarizing conditions for 6 days; CTCM was the primary cell culture medium whereas X-VIVO 20 (Lonza) was used for serum-free cultures. Cells were stimulated with PMA (50 ng/ml), ionomycin (750 ng/ml), and brefeldin A (10 mg/ml) and stained for flow cytometry using the Foxp3/ intracellular staining kit and fixable viability dyes (eBioscience); antibodies: CD4 (GK1.5), CD25 (PC61.5), CCR9 (eBio-CW1.2), Foxp3 (FJK-16s), a4b7 (FIB504), and IL-17a (eBio1787) (eBioscience). Samples analyzed using a LSR-II (BD Biosciences) and FlowJo software (Tree Star).
T reg Suppression Assay
CD4
+ T cells were isolated from spleens and lymph nodes and a PE-selection kit (STEMCELL) was used to further isolate CD25 
RNA Isolation and Quantitative Real-time PCR
RNA was isolated from tissues by mechanical disruption and the TRIzol method (Ambion). RNA was purified from CD4 + T cells using RNeasy mini kits (Qiagen). Reverse transcription was used to generate cDNA and qPCR was performed using SYBR green primer sets. Reactions were run on an ABI 7900 real-time PCR machine (Applied Biosystems). Samples were normalized relative to Actb.
T Cell Transfer Colitis
Spleens and lymph nodes from donor mice were processed for CD4 + T cell isolation. 4.5610 5 
FACS-sorted CD4
+ CD45RB high CD25 2 T cells were transferred into recipient Rag1 2/2 mice intraperitoneally to induce colitis. Weight loss and disease progression were monitored each week. Weight loss of 20% was considered the humane endpoint. Proximal colons were processed for histological hematoxylin and eosin staining and scored for disease (inflammatory cell infiltration, loss of epithelial architecture, thickening of colonic wall). Spleens and mesenteric lymph node (mesLN) cells were stimulated with 1 mg/ml a-CD3/ a-CD28 overnight, then stimulated with PMA, ionomycin, and brefeldin-A for 5 hours, and were intracellularly stained for flow cytometry.
Analysis of CCR9 Expression
CCR9 expression was induced as previously described using transient TCR and IL-2 stimulation [10] . 5610 5 isolated CD4+ T cells were stimulated with or without 10 nM all-trans retinoic acid (atRA) for 2 days (plates coated with 5 mg/ml a-CD3 and 1 mg/ml a-CD28) and then supplemented with 10 ng/ml IL-2 for an additional 2 days with antibodies removed. CCR9 surface expression was measured by flow cytometry.
Statistics
Results are presented as mean 6 SEM. Statistical significance between two groups was determined by unpaired Student's t-test while comparisons between 3 or more groups were made by ANOVA with a Bonferroni post-hoc test using Prism software (GraphPad). Results were considered significant with a P value of ,0.05.
